Generic name/ Classification Mechanism of Indication Contraindication Side effect/ adverse Nursing

brand name action effect responsibility

Methylprednisolone Corticosteroid Enters target cells Short-term Contraindicated with - CNS: Vertigo, headache,  Monitor vital
Glucocorticoid and binds to management of infections, especially paresthesias, insomnia, signs every 15
Brand Name: Hormone intracellular various tuberculosis, fungal seizures, psychosis, minutes for one
Methapred, Solu- corticosteroid inflammatory infections, amebiasis, cataracts, increased IOP, hour.
Medrol receptors, initiating and allergic vaccinia and glaucoma.  Look for
many complex disorders, such varicella, and untoward
Dose: 1, 2 g/vial reactions that are as rheumatoid antibiotic-resistant - CV:Hypot ension, shock,
reaction such as
Powder for injection responsible for its arthritis, collagen infections; lactation; hypertension and CHF
difficulty in
anti-inflammatory diseases (eg, allergy to tartrazine secondary to fluid
breathing and
and SLE), or aspirin in products retention,
itchiness.
thromboembolism,
immunosuppressive dermatologic labeled Medrol.  Regulate IV to
effects. diseases (eg, thrombophlebitis, fat
be consumed
Use cautiously with embolism, cardiac
for one hour.
pemphigus), kidney or liver arrhythmias
status disease,
asthmaticus, and hypothyroidism, - Electrolyte imbalance:
autoimmune ulcerative colitis with Na+ and fluid retention,
disorders impending hypokalemia,
perforation, hypocalcemia Endocrine:
diverticulitis, active Amenorrhea, irregular
or latent peptic ulcer, menses, growth
inflammatory bowel retardation, decreased
disease, CHF, carbohydrate tolerance,
hypertension, diabetes mellitus,
thromboembolic cushingoid state (long-
disorders, term effect), increased
osteoporosis, seizure blood sugar, increased
disorders, diabetes serum cholesterol,
mellitus, pregnancy. decreased T3 and T4
levels, hypothalamic-
pituitary-adrenal (HPA)
suppression with systemic
therapy longer than 5 days
- GI: Peptic or esophageal
ulcer, pancreatitis,
abdominal distention,
nausea, vomiting,
increased appetite, weight
gain
- Hypersensitivity:
Anaphylactoid reactions
- Musculoskeletal: Muscle
weakness, steroid
myopathy, loss of muscle
mass, osteoporosis,
spontaneous fractures
- Other:
Immunosuppression;
aggravation or masking of
infections; impaired
wound healing; thin,
fragile skin; petechiae,
ecchymoses, purpura,
striae; subcutaneous fat
atrophy
 Assessment Nursing Diagnosis Objectives/Planning Interventions Rationale Evaluation

Subjective: Risk for injury  Patient remains free Independent:  After the 8-hour nursing
The patient related to impaired of injuries.  Validate the patient’s  Validation lets the intervention, the client
complaining of sensory function due  Patient explains feelings and concerns patient know that the remains free of injuries
lossing her vision to loss of vision on methods to prevent related to nurse has heard and
on her left eye. right eye injury. environmental risks. understands what was  After the 8-hour nursing
 Patient identifies said, and it promotes intervention, the client can
Objective: the nurse-patient explain methods to prevent
factors that increase
Not applicable; relationship. injury and identifies factors
risk for injury.
that increase risk for injury.

 Ask family or  This is to prevent the

significant others to patient from falling.
be with the patient to
prevent him or her
from accidentally
falling

 Thoroughly conform  The patient must get

patient to
surroundings. Put
call light within
reach and teach how
to call for assistance;
respond to call light
immediately.
used to the layout of
the environment to
avoid accidents.
Items that are too far
from the patientmay
cause hazard.